Latest filing published 25 May 2022 for ARCA biopharma, Inc., €4,944. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Funicular Fund, LP in Oruka Therapeutics, Inc. Over a trading history stretching from 4 April 2022 to 23 May 2022, the count stands at 13 filings.
Purchases make up the whole of the open-market record (13 purchases, €988k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Half of the purchases are above €46k and half below. Across 12 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 25 May 2022 with an open-market purchase (€4,944) in Oruka Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations